FAQ

Acolbifene

Known as: (2S)-3-(4-Hydroxyphenyl)-4-methyl-2-(4-(2-(1-piperidinyl)ethoxy)phenyl)-2H-1-benzopyran-7-ol 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2004-2015
0120042015

Related topics

Related topics

3 relations
EM 652

Narrower (1)

SCH 57068

Broader (1)

ritetronium

Related mentions per year

Related mentions per year

1997-2015
1990200020102020
Acolbifene
EM 652
SCH 57068
ritetronium

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Clinical Trial of Acolbifene in Premenopausal Women at High Risk for Breast Cancer.
The purpose of this study was to assess the feasibility of using the selective estrogen receptor modulator (SERM) acolbifene as a… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2013
2013
Androgenic action of dehydroepiandrosterone (DHEA) on nerve density in the ovariectomized rat vagina.
INTRODUCTION We have recently reported that dehydroepiandrosterone (DHEA) increases the density of nerve fibers in the… (More)
  • figure 1
  • figure 2
Is this relevant?
2012
2012
Specific transcriptional response of four blockers of estrogen receptors on estradiol-modulated genes in the mouse mammary gland
Novel agents for the endocrine therapy of breast cancer are needed, especially in order to take advantage of the multiple… (More)
  • figure 1
  • table 3
  • table 4
  • table 4
  • figure 2
Is this relevant?
2006
2006
Hypocholesterolemic action of the selective estrogen receptor modulator acolbifene in intact and ovariectomized rats with diet-induced hypercholesterolemia.
Acolbifene (ACOL) is a fourth-generation selective estrogen receptor modulator (SERM) that has strong and pure antiestrogenic… (More)
Is this relevant?
2005
2005
Effects of dehydroepiandrosterone, Premarin and Acolbifene on histomorphology and sex steroid receptors in the rat vagina.
To assess the specific estrogenic and/or androgenic effects of a potential novel hormone replacement therapy, we have examined… (More)
Is this relevant?
2005
2005
Estrogen receptor α-mediated adiposity-lowering and hypocholesterolemic actions of the selective estrogen receptor modulator acolbifene
OBJECTIVE:The selective estrogen receptor (ER) modulator (SERM) acolbifene (ACOL), a potent and pure antiestrogen in the mammary… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
2005
2005
Bioactivation of the selective estrogen receptor modulator acolbifene to quinone methides.
Although approved for the treatment of hormone-dependent breast cancer as well as for the prevention of breast cancer in high… (More)
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • figure 5
Is this relevant?
2004
2004
Selective estrogen receptor modulator regulated proteins in endometrial cancer cells.
Tamoxifen is the primary hormonal therapy for breast cancer and is also used as a breast cancer chemopreventative agent. A major… (More)
Is this relevant?